INTERPACE BIOSCIENCES, INC. Gross Profit

Quick Answer

INTERPACE BIOSCIENCES, INC. reported Gross Profit of $24.13 million for the year ending 2025.

  • INTERPACE BIOSCIENCES, INC. showed a decrease of -19.4% in Gross Profit from 2024 to 2025.
  • This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2012: $6.57 million | Q3 2012: $5.94 million | Q1 2013: $8.47 million | Q2 2013: $6.85 million | Q3 2013: $4.70 million | Q1 2014: $5.12 million | Q2 2014: $5.19 million | Q3 2014: $3.85 million | Q1 2015: $543.0 thousand | Q2 2015: $402.0 thousand | Q3 2015: $707.0 thousand | Q1 2016: $1.86 million | Q2 2016: $1.77 million | Q3 2016: $1.47 million | Q1 2017: $1.70 million | Q2 2017: $1.98 million | Q3 2017: $2.13 million | Q1 2018: $2.23 million | Q2 2018: $3.25 million | Q3 2018: $2.99 million | Q1 2019: $3.39 million | Q2 2019: $3.24 million | Q3 2019: $2.89 million | Q1 2020: $2.95 million | Q2 2020: $1.60 million | Q3 2020: $3.05 million | Q1 2021: $4.52 million | Q2 2021: $5.36 million | Q3 2021: $4.44 million | Q1 2022: $4.66 million | Q2 2022: $3.83 million | Q3 2022: $4.73 million | Q1 2023: $6.14 million | Q2 2023: $7.22 million | Q3 2023: $5.38 million | Q1 2024: $6.31 million | Q2 2024: $7.81 million | Q3 2024: $7.90 million | Q1 2025: $7.37 million | Q2 2025: $5.28 million | Q3 2025: $5.44 million.
  • Over the full 16 years of available data (2010 to 2025), INTERPACE BIOSCIENCES, INC.'s Gross Profit has declined by 9.1%.
  • Historical annual values: Fiscal year 2025: $24.13 million | Fiscal year 2024: $29.93 million | Fiscal year 2023: $25.06 million | Fiscal year 2022: $18.23 million | Fiscal year 2021: $18.80 million | Fiscal year 2020: $10.73 million | Fiscal year 2019: $8.33 million | Fiscal year 2018: $11.70 million | Fiscal year 2017: $8.54 million | Fiscal year 2016: $6.44 million | Fiscal year 2015: $2.52 million | Fiscal year 2014: $206.0 thousand | Fiscal year 2013: $23.51 million | Fiscal year 2012: $26.86 million | Fiscal year 2011: $32.47 million | Fiscal year 2010: $26.55 million.
  • Data sourced from SEC EDGAR public filings as of August 8, 2026.

Last verified: